Amneal Pharmaceuticals Inc (AMRX)
6.815
+0.06
(+0.96%)
USD |
NASDAQ |
May 17, 16:00
6.815
0.00 (0.00%)
Pre-Market: 20:00
Amneal Pharmaceuticals Shareholders Equity (Quarterly): -63.72M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -63.72M |
December 31, 2023 | 19.78M |
September 30, 2023 | 330.86M |
June 30, 2023 | 318.17M |
March 31, 2023 | 294.41M |
December 31, 2022 | 298.42M |
September 30, 2022 | 297.47M |
June 30, 2022 | 280.33M |
March 31, 2022 | 391.12M |
December 31, 2021 | 360.34M |
September 30, 2021 | 350.51M |
June 30, 2021 | 346.11M |
March 31, 2021 | 323.02M |
Date | Value |
---|---|
December 31, 2020 | 303.27M |
September 30, 2020 | 301.04M |
June 30, 2020 | 306.00M |
March 31, 2020 | 318.38M |
December 31, 2019 | 232.01M |
September 30, 2019 | 218.00M |
June 30, 2019 | 459.66M |
March 31, 2019 | 472.20M |
December 31, 2018 | 504.75M |
September 30, 2018 | 501.10M |
June 30, 2018 | 494.50M |
December 31, 2017 | -385.74M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-63.72M
Minimum
Mar 2024
459.66M
Maximum
Jun 2019
284.26M
Average
304.63M
Median
Shareholders Equity (Quarterly) Benchmarks
Fate Therapeutics Inc | 426.12M |
Ocular Therapeutix Inc | 407.98M |
Editas Medicine Inc | 294.40M |
AnaptysBio Inc | 47.78M |
AEON Biopharma Inc | -- |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 3.456B |
Total Liabilities (Quarterly) | 3.473B |
Debt to Equity Ratio | -41.31 |
Current Ratio | 1.654 |
Net Debt Paydown Yield | 0.96% |